Brunei has announced a tender invitation for the Benralizumab 30mg ml Solution for Injection, aimed at improving structural stability and addressing erosion concerns in the tender area. The tender is situated in Brunei, and it represents a key infrastructure initiative designed to enhance safety and environmental resilience. The tender is scheduled to close on 26 Sep 2026, giving interested contractors ample time to review requirements and submit their bids. The official tender notice number is not specified, while the WWW Reference Number is 13259966. Eligible bidders and organizations are encouraged to access the detailed tender documents and specifications to gain comprehensive information about project scope, eligibility criteria, and submission procedures.To download the complete tender documents, bidders are required to register on the website.

Tender Details
Title Benralizumab 30mg ml Solution for Injection
WWT Ref No13259966
Tender No

PPS/QTN/93/2026

Country

Brunei

Financer Name

Self-Funded

SummaryTenders are invited for Benralizumab 30mg ml Solution for Injection Supply and Delivery of Medicine for the Department of Pharmaceutical Services Ministry of Health Fee BND Fee BND 5 00 Department Requestor Fee BND AHLI KIMIA UBAT BAHAGIAN PEROLEHAN FARMASI KEMENTERIAN KESIHATAN
Deadline *
Deadline26 Sep 2026
Publishing Date *
Publishing Date30 Aug 2026
Tender Documents
Related DocumentsRelated Document
WhatsApp